Talicia

Active Ingredient(s): Amoxicillin + Omeprazole Magnesium + Rifabutin
FDA Approved: * November 1, 2019
Pharm Company: * REDHILL
Category: Gastrointestinal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Talicia Overview

Helicobacter pylori eradication protocols is a standard name for all treatment protocols for peptic ulcers and gastritis in the presence of Helicobacter pylori infection. The primary goal is not only temporary relief of symptoms but also total elimination of H. pylori infection. Patients with active duodenal or gastric ulcers and those with a prior ulcer history should be tested for H. pylori. Appropriate therapy should be given for eradication. Patients with MALT lymphoma should also be test...

Read more Talicia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Helicobacter_pylori_eradication_protocols

Recent Talicia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amoxicillin + Omeprazole Magnesium + Rifabutin
  • Capsule, Delayed Release: 250mg + 10mg + 12.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Talicia: (1 result)

Sorted by National Drug Code
  • 57841-1150 Talicia Oral Capsule, Delayed Release by Redhill Biopharma Ltd

Drugs with one or more similar ingredients: (21 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA